Correction: Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity.
Yi YangSiqi WangJiaoyang CaiJianwei LiangYingwen ZhangYangyang XieFei LuoJingyan TangYijin GaoShuhong ShenHaizhong FengYanxin LiPublished in: Cellular oncology (Dordrecht) (2023)
Keyphrases